{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,24]],"date-time":"2025-03-24T14:40:23Z","timestamp":1742827223932,"version":"3.40.2"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,3,24]]},"DOI":"10.7759\/cureus.81079","type":"journal-article","created":{"date-parts":[[2025,3,24]],"date-time":"2025-03-24T14:11:55Z","timestamp":1742825515000},"source":"Crossref","is-referenced-by-count":0,"title":["Isolated Neuropathic Bladder Associated With Human T-lymphotropic Virus Type 1 Infection Precipitating Acute Focal Bacterial Nephritis: A Case Report"],"prefix":"10.7759","author":[{"given":"Takahiro","family":"Minamii","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinpei","family":"Mizuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yohei","family":"Kanzawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoto","family":"Ishimaru","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2016.10.015","article-title":"Reducing the global burden of HTLV-1 infection: an agenda for research and action","volume":"137","author":"Willems L","year":"2017","unstructured":"Willems L, Hasegawa H, Accolla R, et al.. Reducing the global burden of HTLV-1 infection: an agenda for research and action. Antiviral Res. 2017, 137:41-8. 10.1016\/j.antiviral.2016.10.015","journal-title":"Antiviral Res"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-011-0934-4","article-title":"Current status of HTLV-1 infection","volume":"94","author":"Watanabe T","year":"2011","unstructured":"Watanabe T. Current status of HTLV-1 infection. Int J Hematol. 2011, 94:430-4. 10.1007\/s12185-011-0934-4","journal-title":"Int J Hematol"},{"key":"ref3","article-title":"The risk of development of HTLV-I-associated myelopathy\/tropical spastic paraparesis among persons infected with HTLV-I","volume":"3","author":"Kaplan JE","year":"1990","unstructured":"Kaplan JE, Osame M, Kubota H, et al.. The risk of development of HTLV-I-associated myelopathy\/tropical spastic paraparesis among persons infected with HTLV-I. J Acquir Immune Defic Syndr. 1990, 3:1096-101.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1097\/00042560-199802010-00011","article-title":"Incidence of HTLV-I-associated myelopathy\/tropical spastic paraparesis (HAM\/TSP) in Jamaica and Trinidad","volume":"17","author":"Maloney EM","year":"1998","unstructured":"Maloney EM, Cleghorn FR, Morgan OS, et al.. Incidence of HTLV-I-associated myelopathy\/tropical spastic paraparesis (HAM\/TSP) in Jamaica and Trinidad. J Acquir Immune Defic Syndr Hum Retrovirol. 1998, 17:167-70. 10.1097\/00042560-199802010-00011","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.48.2.315","article-title":"HTLV-associated myelopathy in a cohort of HTLV-I and HTLV-II-infected blood donors","volume":"48","author":"Murphy EL","year":"1997","unstructured":"Murphy EL, Fridey J, Smith JW, et al.. HTLV-associated myelopathy in a cohort of HTLV-I and HTLV-II-infected blood donors. Neurology. 1997, 48:315-20. 10.1212\/wnl.48.2.315","journal-title":"Neurology"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000096011.92542.da","article-title":"Prevalence and clinical features of HTLV neurologic disease in the HTLV Outcomes Study","volume":"61","author":"Orland JR","year":"2003","unstructured":"Orland JR, Engstrom J, Fridey J, et al.. Prevalence and clinical features of HTLV neurologic disease in the HTLV Outcomes Study. Neurology. 2003, 61:1588-94. 10.1212\/01.wnl.0000096011.92542.da","journal-title":"Neurology"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2015.12","article-title":"HTLV-1-associated myelopathy\/tropical spastic paraparesis","volume":"1","author":"Bangham CR","year":"2015","unstructured":"Bangham CR, Araujo A, Yamano Y, Taylor GP. HTLV-1-associated myelopathy\/tropical spastic paraparesis. Nat Rev Dis Primers. 2015, 1:15012. 10.1038\/nrdp.2015.12","journal-title":"Nat Rev Dis Primers"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1086\/595855","article-title":"Isolated bladder dysfunction in human T lymphotropic virus type 1 infection","volume":"48","author":"Silva MT","year":"2009","unstructured":"Silva MT, Coutinho F, Leite AC, Harab RC, Ara\u00fajo A, Andrada-Serpa MJ. Isolated bladder dysfunction in human T lymphotropic virus type 1 infection. Clin Infect Dis. 2009, 48:e34-6. 10.1086\/595855","journal-title":"Clin Infect Dis"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3978\/j.issn.2223-4683.2016.01.06","article-title":"Urinary tract infection in the neurogenic bladder","volume":"5","author":"Vigil HR","year":"2016","unstructured":"Vigil HR, Hickling DR. Urinary tract infection in the neurogenic bladder. Transl Androl Urol. 2016, 5:72-87. 10.3978\/j.issn.2223-4683.2016.01.06","journal-title":"Transl Androl Urol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-017-2336-6","article-title":"Acute focal bacterial nephritis is associated with invasive diagnostic procedures - a cohort of 138 cases extracted through a systematic review","volume":"17","author":"Sieger N","year":"2017","unstructured":"Sieger N, Kyriazis I, Schaudinn A, et al.. Acute focal bacterial nephritis is associated with invasive diagnostic procedures - a cohort of 138 cases extracted through a systematic review. BMC Infect Dis. 2017, 17:240. 10.1186\/s12879-017-2336-6","journal-title":"BMC Infect Dis"},{"key":"ref11","unstructured":"Neuro-urology. (2020). Accessed. September 2, 2024: https:\/\/uroweb.org\/guideline\/neuro-urology\/."},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ucl.2017.04.003","article-title":"Long-term complications of the neurogenic bladder","volume":"44","author":"Nseyo U","year":"2017","unstructured":"Nseyo U, Santiago-Lastra Y. Long-term complications of the neurogenic bladder. Urol Clin North Am. 2017, 44:355-66. 10.1016\/j.ucl.2017.04.003","journal-title":"Urol Clin North Am"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/315331-isolated-neuropathic-bladder-associated-with-human-t-lymphotropic-virus-type-1-infection-precipitating-acute-focal-bacterial-nephritis-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,24]],"date-time":"2025-03-24T14:12:10Z","timestamp":1742825530000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/315331-isolated-neuropathic-bladder-associated-with-human-t-lymphotropic-virus-type-1-infection-precipitating-acute-focal-bacterial-nephritis-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,24]]},"references-count":12,"URL":"https:\/\/doi.org\/10.7759\/cureus.81079","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3,24]]}}}